Articles published by GlobeNewswire

...

Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Today 8:00 EDT

From Atsena Therapeutics

Via GlobeNewswire

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

Today 8:00 EDT

From Helus Pharma

Via GlobeNewswire

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Today 8:00 EDT

From Ardelyx, Inc.

Via GlobeNewswire

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

Today 8:00 EDT

From Tenvie Therapeutics, Inc.

Via GlobeNewswire

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

Today 8:00 EDT

From LENZ Therapeutics, Inc.

Via GlobeNewswire

Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth

Today 8:00 EDT

From Commerce.com, Inc.

Via GlobeNewswire

AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease

Today 8:00 EDT

From AskBio Inc. (AskBio)

Via GlobeNewswire

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Today 8:00 EDT

From Boehringer Ingelheim Limited

Via GlobeNewswire

Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks

Today 8:00 EDT

From Kyverna Therapeutics, Inc.

Via GlobeNewswire

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

Today 8:00 EDT

From Phathom Pharmaceuticals

Via GlobeNewswire

RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue

Today 7:50 EDT

From RedCloud Holdings plc

Via GlobeNewswire

NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference

Today 7:37 EDT

From NewcelX Ltd.

Via GlobeNewswire

Nexera: KeepZone AI Enters into White Label Agreement to Develop its AI-Based Voice Communication Decision Support System

Today 7:32 EDT

From Nexera Technologies Ltd

Via GlobeNewswire

Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region

Today 7:30 EDT

From Biogen Inc.

Via GlobeNewswire

Palvella Therapeutics to Present QTORIN™ Rapamycin Results from Phase 3 SELVA and Phase 2 TOIVA Studies at the International Society for the Study of Vascular Anomalies World Congress 2026

Today 7:30 EDT

From Palvella Therapeutics Inc.

Via GlobeNewswire

Cronos Group Inc. to Hold 2026 First Quarter Earnings Conference Call on May 11, 2026

Today 7:30 EDT

From Cronos Group Inc.

Via GlobeNewswire

Weight Watchers Appoints Proven Healthcare Executive Heather Thiltgen to Board of Directors

Today 7:30 EDT

From WW International Inc.

Via GlobeNewswire

Swvl Announces FY 2025 Results; Revenue Up 41% to $24.2 million; Net Income $1.3 million; NDR of 128%; GCC Revenue Up 122%

Today 7:30 EDT

From Swvl Holdings Corp

Via GlobeNewswire

New Found Gold Announces $205M Finance Package

Today 7:15 EDT

From New Found Gold Corp.

Via GlobeNewswire

Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial

Today 7:15 EDT

From Clearmind Medicine Inc.

Via GlobeNewswire

Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit

Today 7:01 EDT

From Invivyd

Via GlobeNewswire

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Today 7:00 EDT

From Lumexa Imaging, Inc.

Via GlobeNewswire

Passage Bio Reports Updated Interim Data from upliFT-D Trial and Provides Regulatory and Corporate Updates

Today 7:00 EDT

From Passage Bio

Via GlobeNewswire

SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform

Today 7:00 EDT

From SPARC AI INC

Via GlobeNewswire

TransAlta Appoints Mike Politeski as Chief Financial Officer and Grant Arnold as Chief Commercial Officer

Today 7:00 EDT

From TransAlta Corporation

Via GlobeNewswire

Soleo Health Expands Rare Disease Capabilities With Launch of SoleoRare™, A Specialty Pharmacy Focused on Complex Patient Needs

Today 7:00 EDT

From Soleo Health Holdings, Inc.

Via GlobeNewswire

Aikido Security Launches Endpoint Protection for Developer Devices as Software Supply Chain Attacks Hit Unprecedented Scale

Today 7:00 EDT

From Aikido Security

Via GlobeNewswire

NRx Pharmaceuticals (Nasdaq:NRXP) Welcomes Presidential Initiative to Accelerate Approval of Psychedelic Medications to Treat Depression, PTSD, and Suicidality

Today 7:00 EDT

From NRx Pharmaceuticals, Inc.

Via GlobeNewswire

Altus Group Announces Exemptive Relief from the Ontario Securities Commission in connection with its Substantial Issuer Bid

Today 7:00 EDT

From Altus Group Limited

Via GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors

Today 7:00 EDT

From Monte Rosa Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.